Meet PhenOM^®

AI has been a buzzword in healthcare for years. The concept can seem daunting, and many hyped up applications have fallen short of their potential.

At OM1, we can go further than point solutions (model for X) and are using AI to really understand patients at a deep level, like a genetic test.

That future is here — meet PhenOM^®

We’re on a mission to empower life sciences companies and providers to make accurate, explainable, and actionable predictions of health risks on an individual and population level.

PhenOM uses OM1’s repository of linked EMR, claims and other data covering more than 340 million patients to generate digital phenotypes. The richness of the source data let these phenotypes capture many complex facets of the target patients’ journeys.

» Check out a video about PhenOM

How does it work?

Pick the patient group of interest – everyone diagnosed with a disease, for example, or those treated with a specific medication.

Isolate what’s unique about these patients and build a phenotypic ‘fingerprint’ for them.

Study the phenotype to generate new insights or deploy it to focus on specific patients.

Core PhenOM^® Solutions

OM1 offers three solutions built on PhenOM and designed around different ways to deliver PhenOM insights. In each, the analytic process remains the same: based in large cohorts of real-world patients with target characteristics, PhenOM identifies unique data ‘fingerprints’ that can be studied and applied prospectively to answer research questions and find patients.

Meet OM1 Orion

Pathfinder through patient journeys

Experience the seamless fusion of AI technology and clinically robust RWD with Orion.

Unveiling a comprehensive view of disease progression and burden for patient subpopulations, Orion enables the discovery and diagnosing of unmet needs, real-world drivers and barriers, and patient patterns, offering a perspective on the patient journey like never before.

Orion AI insights can augment traditional datasets

Meet OM1 Lyra

Harmonizing data for personalized insights at the point of care

A singular focus on one instrument risks missing the harmony of the entire song. Discover new patient populations with Lyra, the next-generation AI platform that is perfectly harmonized with RWD.

Generate and stratify predictions around diagnosis, treatment, and safety response and preemptively intervene.

Lyra works at the patient level to harmonize data for targeted insights

Meet OM1 Polaris

Precision phenotyping to guide clinical research

Let Polaris guide you to the most highly suitable patients for your clinical trial. Polaris, a next-gen AI platform, leverages RWD-predicted outcomes to highlight, stratify, and locate patients, investigators, and sites, informing you of the strongest trial design.

Expand scope to find more patients for your clinical trials with OM1 Polaris

Insights PhenOM^® can provide

I know patients in my disease area are missing – either misdiagnosed, impossible to identify in available datasets, or undiagnosed entirely. Screening programs may exist but adherence is poor and gaps remain.

Some patients within my focus area are at particular risk – for example, of rapid progression to more serious disease – and knowing who they are in advance could help focus and reduce their risk.

Patients with disproportionate growth in utilization face especially severe burdens. Understanding what’s unique about this group within my disease space can help inform strategy and treatment access.

Effective treatments exist – particularly for subsets of patients – but use does not match expert guidelines around who’d benefit and should have access. I need to know where to start in closing this gap.

I know there are more patients out there than we’ve been successful in recruiting – including some at sites we’ve already activated, and potentially ‘off the radar’ too.